scRNAseq Service

Homepage > Services

Singleron offers a complete single-cell sequencing service with focus on clinical researches, based on the SCOPE single cell kits, software and meaningful annotation of data. The intergreted results allow clinicians a new comprehensive view on molecular correlations and progression of certain diseases. Until today more than 8000 samples (surgical samples, biopsies, PBMC and others) from over 350 different tissue types have been successfully sequenced and analyzed.


Single Cell Sequencing Service, clinical meaningful analysis
  • Project Consultation
  • Design experiment plan
  • Sample shipment
  • Single Cell Suspension Preparation
  • Single Cell RNAseq library construction
  • Sequencing
  • Bioinformatic Analysis 
  • Report
Sample Requirement
Sample Type Appearance Weight Status Temperature Storage duration
Tissue no leak, label intact, within temperature range ≥100mg fresh tissue 2-8℃ <72h
Fresh Blood(EDTA) no leak, label intact, within temperature range ≥5mg no hemolysis 2-8℃ <72h
Biopsy no leak, label intact, within temperature range ≥3 pieces fresh biopsy 2-8℃ <72h
Extensive Single Cell project experiences
Project experiences
  • 2000+ projects
  • 100,000,000+ single cell sequenced
  • Tissue
  • Surgical Biopsy
  • Needle Biopsy
  • PBMC
  • Other cell lines
  • Human and mouse focused database
Sample Types
  • Lung 
  • Liver
  • Ovary
  • Prostate
  • laryngeal
  • brain
  • Breast
  • Bone
  • Whole Blood
Successful Rate
Tissue sample successful rate
  • surgical biopsy:97.3%
  • needle biopsy:87%
  • PBMC:100%
What our customers say:

When we started with our single-cell RNAseq study of osteosarcoma, we encountered a challenge immediately after acquiring the tumor samples: it was nearly impossible to be dissociated to highly viable single cell suspension that is required for single cell sequencing, even with multiple attempts using in-house and commercial kits.  Following suggestions from a colleague, we used Singleron sCelLiVE Tissue Dissociation Solution which could beautifully dissociate osteosarcoma samples with a straightforward protocol. This made it possible for us to move forward successfully with our project which resulted in an osteosarcoma single-cell atlas showing cellular heterogeneity and potential therapeutic targets and a publication in Nature Communications.

Dr. Haiyan Hu

Chief Physician, Oncology Department

Shanghai Jiao Tong University,  The Sixth People’s Hospital Shanghai, China




Contact Us

Phone:+49 221 16824777 (German office)

Address:Singleron Biotechnologies GmbH, Gottfried-Hagen-Strasse 60, 51105 Cologne, Germany

Copyright © 2021 Singleron Biotechnologies.Design:Huake

苏ICP备19004238号-1 苏公网安备32011202000658号